Zou Chu Guo Men – Developing a Successful Strategy for Entering the U.S. Market
April 19, 2011
Foley is again proud to co-host the ChinaBio Executive Workshop in Guangzhou on April 19, 2011. This half-day, complimentary seminar will explore critical aspects of developing an effective going-out strategy and a plan to protect and leverage your life sciences technology and intellectual capital in the U.S. market. Topics include:
- Key 2010 developments in China’s life sciences industry and the current status of the Zou Chu Guo Men policy
- Entering the U.S. market via strategic alliances, joint ventures, direct investment, and other strategic collaborations
- Investing in life sciences companies in the United States
- Maximizing returns on investments via the art and science of patent prosecution
- Commercializing China-originated technology in the United States
Speakers
- Hon. Sharon R. Barner, Foley Partner and Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the USPTO (2009 – 2011)
- Stephen A. Bent, Foley Partner and member of the firm’s Chemical, Biotechnology & Pharmaceutical Practice and Health Care and Nanotechnology Industry Teams
- James C. Chapman, Foley Partner and member of the firm’s Private Equity & Venture Capital Practice and Emerging Technologies Industry Team
- James F. Ewing, Foley Partner, Vice Chair of the firm’s Chemical, Biotechnology & Pharmaceutical Practice, and member of the firm’s Life Sciences, Food, and Nanotechnology Industry Teams
- Greg B. Scott, President and Founder, ChinaBio LLC
Co-Sponsor:
For more information, contact Delia Dai at [email protected] or (001) 312.832.4506, or Monica Cheng at [email protected] or (86) 21.5137.0751.
People
Related Insights
December 19, 2025
Health Care Law Today
Gender Affirming Care for Minors: CMS and HHS Propose Limits on “Sex Rejection Procedures” and Expanded Enforcement Pathways
On December 18, 2025, the U.S. Department of Health and Human Services (HHS) held a press conference focused on what is defined as “sex…
December 19, 2025
Foley Viewpoints
Prohibition to Prescription: What Trump’s Marijuana Executive Order Really Means
On December 18, 2025, President Donald Trump issued an Executive Order, Increasing Medical Marijuana and Cannabidiol Research, that…
December 18, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…